Successful treatment of hypnic headache syndrome with acetazolamide.
Sibon
Igor
I
Group Hospitalier Pellegrin, Service de Neurologie du Professeur Orgogozo, Bordeaux, France. igor.sibon@chu-bordeaux.fr
Ghorayeb
Imad
I
Henry
Patrick
P
D000086:Acetazolamide / Q000627:therapeutic use*; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use*; D004172:Diplopia / Q000139:chemically induced; D020329:Essential Tremor / Q000150:complications; D005260:Female; D020773:Headache Disorders / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000150:complications; D007213:Indomethacin / Q000009:adverse effects; D012008:Recurrence; D012893:Sleep Wake Disorders / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D013577:Syndrome; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002257:Carbonic Anhydrase Inhibitors; D000086:Acetazolamide; D007213:Indomethacin